No Myth: CEO of ADC up­start calls it quits; Bris­tol My­ers vet Jon Wig­gin­ton scales new heights at Bright Peak

→ When Myth­ic Ther­a­peu­tics CEO Alex Nichols spoke to End­points News last De­cem­ber about the biotech’s $103 mil­lion Se­ries B, he and fel­low co-founder Bri­an Fiske em­pha­sized safe­ty, say­ing that they’re “re­al­ly work­ing on try­ing to over­come what has been one of the most his­tor­i­cal­ly chal­leng­ing ob­sta­cles to re­al­iz­ing the full po­ten­tial of AD­Cs.” But Myth­ic will have to look for some­one else to take up that man­tle.

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP LOG IN